Tools
Tools
Forbes, Alastair 
ORCID: https://orcid.org/0000-0001-7416-9843, Johnson, Philip J. and Williams, Roger
(1985)
Recombinant human gamma-interferon in primary hepatocellular carcinoma.
Journal of the Royal Society of Medicine, 78 (10).
pp. 826-829.
ISSN 0141-0768
Abstract
A phase II trial of recombinant human gamma-interferon in the treatment of unresectable primary hepatocellular carcinoma is reported. The trial was terminated prematurely after recruitment of only 7 patients because of unacceptable toxicity, predominantly renal. There was no evidence of response in any of the 7 patients but some evidence that disease progression was more rapid during the treatment period.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | adult,carcinoma, hepatocellular,drug evaluation,female,humans,interferon-gamma,liver neoplasms,male,middle aged,time factors,alpha-fetoproteins,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology |
| Depositing User: | Pure Connector |
| Date Deposited: | 06 Aug 2014 10:44 |
| Last Modified: | 24 Oct 2022 23:58 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/49496 |
| DOI: | 10.1177/014107688507801007 |
Actions (login required)
 |
View Item |